Symbol="DAWN"
AssetType="Common Stock"
Name="Day One Biopharmaceuticals Inc"
Description="Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and markets targeted therapies for patients with genetically defined cancers. The company is headquartered in South San Francisco, California."
CIK="1845337"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="395 OYSTER POINT BLVD STE 217, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="974366000"
EBITDA="-164952992"
PERatio="None"
PEGRatio="None"
BookValue="4.083"
DividendPerShare="0"
DividendYield="0"
EPS="-2.14"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.349"
ReturnOnEquityTTM="-0.56"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.14"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="40.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.153"
EVToRevenue="-"
EVToEBITDA="-9.02"
Beta="-2.077"
num_52WeekHigh="28.35"
num_52WeekLow="10.84"
num_50DayMovingAverage="13.08"
num_200DayMovingAverage="17.75"
SharesOutstanding="86842000"
DividendDate="None"
ExDividendDate="None"
symbol="DAWN"
open="11.63"
high="11.73"
low="11.17"
price="11.22"
volume="2658150.00"
latest_trading_day="2023-07-06"
previous_close="11.78"
change="-0.56"
change_percent="-4.7538%"
aroon_positive_momentum_days="19"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="19"
Volume_recent_avg="1079334"
Change_recent_avg="-0.11"
Delta_recent_avg="0.92"
Variance_recent_avg="0.46"
Change_ratio_recent_avg="-0.82"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_10"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="19"
Aroon_momentum_negative="81"
image_negative_thumbnail_id_1="147"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0029.jpeg"
image_negative_thumbnail_id_2="103"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0073.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="616"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_positive_thumbnail_id_2="675"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
